Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Alworth, L
Simmons, J
Franklin, C
and
Fish, R
2009.
Clostridial typhlitis associated with topical antibiotic therapy in a Syrian hamster.
Laboratory Animals,
Vol. 43,
Issue. 3,
p.
304.
Garcia-Tsao, Guadalupe
and
Surawicz, Christina M
2010.
Clostridium difficile Infection: Yet Another Predictor of Poor Outcome in Cirrhosis.
American Journal of Gastroenterology,
Vol. 105,
Issue. 1,
p.
114.
Azam, Mohammad
and
Farrell, Richard J.
2010.
Inflammatory Bowel Disease.
p.
619.
Koya, V.
Campbell, A. M.
McLaughlin, P. J.
Tewari, D.
Wilson, R. P.
and
Cooper, T. K.
2012.
Outbreak of Abdominal Distension and Obstipation in a C57BL/6J Experimental Autoimmune Encephalomyelitis Study.
Veterinary Pathology,
Vol. 49,
Issue. 3,
p.
528.
Surawicz, Christina M
Brandt, Lawrence J
Binion, David G
Ananthakrishnan, Ashwin N
Curry, Scott R
Gilligan, Peter H
McFarland, Lynne V
Mellow, Mark
and
Zuckerbraun, Brian S
2013.
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections.
American Journal of Gastroenterology,
Vol. 108,
Issue. 4,
p.
478.
Mullen, Kevin D.
Sanyal, Arun J.
Bass, Nathan M.
Poordad, Fred F.
Sheikh, Muhammad Y.
Frederick, R. Todd
Bortey, Enoch
and
Forbes, William P.
2014.
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy.
Clinical Gastroenterology and Hepatology,
Vol. 12,
Issue. 8,
p.
1390.
Peto, Philippa
Kubelka, Igor
and
Jayawardene, Satish
2014.
A Complex Case of Diarrhea.
Infectious Diseases in Clinical Practice,
Vol. 22,
Issue. 2,
p.
110.
Ponziani, Francesca Romana
2015.
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
World Journal of Gastroenterology,
Vol. 21,
Issue. 43,
p.
12322.
Trifan, A.
Stoica, O.
Stanciu, C.
Cojocariu, C.
Singeap, A.-M.
Girleanu, I.
and
Miftode, E.
2015.
Clostridium difficile infection in patients with liver disease: a review.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 34,
Issue. 12,
p.
2313.
Bouza, E.
Alcalá, L.
Marín, M.
Valerio, M.
Reigadas, E.
Muñoz, P.
González-Del Vecchio, M.
and
de Egea, V.
2017.
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 36,
Issue. 10,
p.
1777.
Khanafer, Nagham
Vanhems, Philippe
Barbut, Frédéric
and
Luxemburger, Christine
2017.
Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
Anaerobe,
Vol. 44,
Issue. ,
p.
117.
Reigadas, Elena
Alcalá, Luis
Gómez, Javier
Marín, Mercedes
Martin, Adoración
Onori, Raffaella
Muñoz, Patricia
and
Bouza, Emilio
2018.
Breakthrough Clostridium difficile Infection in Cirrhotic Patients Receiving Rifaximin.
Clinical Infectious Diseases,
Vol. 66,
Issue. 7,
p.
1086.
Smith, Elliot Z.
Northup, Patrick G.
and
Argo, Curtis K.
2018.
Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.
Journal of Clinical Gastroenterology,
Vol. 52,
Issue. 8,
p.
747.
Chen, Yunbo
Gui, Qiaodi
Xu, Qiaomai
Lv, Tao
Gu, Silan
Shen, Ping
Quan, Jiazheng
Fang, Yunhui
Ye, Guangyong
and
Li, Lanjuan
2018.
Clostridium difficile Infection Among Hospitalized Chronic Hepatitis B Virus-Infected Patients in a Chinese Hospital.
Jundishapur Journal of Microbiology,
Vol. 11,
Issue. 9,
Sakamaki, Akira
Takamura, Masaaki
and
Terai, Shuji
2019.
The Evolving Landscape of Liver Cirrhosis Management.
p.
79.
Kruger, Andrew J.
Durkin, Claire
Mumtaz, Khalid
Hinton, Alice
and
Krishna, Somashekar G.
2019.
Early Readmission Predicts Increased Mortality in Cirrhosis Patients After Clostridium difficile Infection.
Journal of Clinical Gastroenterology,
Vol. 53,
Issue. 8,
p.
e322.
Hong, Simon J.
Feuerstadt, Paul
and
Brandt, Lawrence J.
2019.
MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection.
Digestive and Liver Disease,
Vol. 51,
Issue. 2,
p.
275.
Feuerstadt, Paul
Hong, Simon J.
and
Brandt, Lawrence J.
2020.
Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
Digestive Diseases and Sciences,
Vol. 65,
Issue. 2,
p.
632.
Sahra, Syeda
Abureesh, Mohammad
Amarnath, Shivantha
Alkhayyat, Motasem
Badran, Rawan
Jahangir, Abdullah
and
Gumaste, Vivek
2021.
Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States.
World Journal of Hepatology,
Vol. 13,
Issue. 8,
p.
926.
Dudzicz-Gojowy, Sylwia
Więcek, Andrzej
and
Adamczak, Marcin
2022.
Clostridioides difficile Infection in Patients after Organ Transplantation—A Narrative Overview.
Journal of Clinical Medicine,
Vol. 11,
Issue. 15,
p.
4365.